Skip to main content
Premium Trial:

Request an Annual Quote

Genomics Collaborative Hires GeneticXchange for 5-year Software Deal

NEW YORK, March 26 – Genomics Collaborative has hired GeneticXchange to provide data integration software to the company and its academic collaborators over a period of five-years, the companies said Monday.

The agreement extends a year-old relationship between the two companies, in which Genomics Collaborative (GCI), a Cambridge, Mass., functional genomics company, has non-exclusively licensed gX-Engine, GeneticXchange’s data access and integration software.

In addition, GCI executives will now sit on the product board of GeneticXchange to help direct software development and integrate the two companies R&D, said Jeff Edwards, chief operating officer at GeneticXchange.

“Last year we entered into a small consulting arrangement, but that’s now a five-year collaboration, and [GCI] is making us an integral part of their infrastructure,” said Edwards.

GX-Engine, according to Edwards, allows GCI to access disparate public and proprietary databases and algorithms, combine the information in a standard format, and perform multiple searches.

GCI performs disease association studies, target validation, and tissue-based studies to develop pharmaceutical and pharmacogenomics capabilities.

GeneticXchange, based in Menlo Park, Calif., currently has collaborations with Signature Biosciences, a biotechnology company, and several academic research institutions, including Stanford University. In mid-April, the company plans to release a desktop biological pathway visualization and data integration tool, called Pathvision, Edwards said.  
The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.